Drug interactions
Empagliflozin-linagliptin + Estrogens conjugated synthetic
Severity: Minor
Empagliflozin-linagliptin and Estrogens conjugated synthetic: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Estrogens are not meaningful CYP3A4 inducers, so no important pharmacokinetic effect on linagliptin is expected. Estrogens can slightly impair glucose tolerance, but the effect is usually minor.
What this interaction means in plain words
Empagliflozin-linagliptin and Estrogens conjugated synthetic have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
No established pharmacokinetic mechanism; estrogens may modestly alter glucose tolerance.
What to do
No dose adjustment is needed; monitor blood glucose routinely.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Estrogens conjugated synthetic, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Frequently asked questions
Can I take Empagliflozin-linagliptin with Estrogens conjugated synthetic?
MediHelp rates the interaction as minor. Empagliflozin-linagliptin and Estrogens conjugated synthetic have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Estrogens are not meaningful CYP3A4 inducers, so no important pharmacokinetic effect on linagliptin is expected. Estrogens can slightly impair glucose tolerance, but the effect is usually minor.
How serious is the interaction between Empagliflozin-linagliptin and Estrogens conjugated synthetic?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; monitor blood glucose routinely.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
